Stock Movers
Stock Movers

Aug 28, 2026 · 7 min

PayPal deal collapse rattles fintech as Affirm gains

Paypal Sinks on Abandoned Deal, Affirm Rallies, BioNTech Slumps

The episode captures how abandoned dealmaking, consumer-credit signals, and a clinical setback are reshaping sentiment across fintech and biotech.

3 key takeaways
  1. 1PayPal shares fell after Advent and Stripe abandoned a potential buyout valued at more than $50 billion.
  2. 2Affirm rallied on a stronger revenue forecast, earnings growth, and continued expansion of its Shopify partnership.
  3. 3BioNTech declined after ending a personalized mRNA cancer-vaccine trial with Roche despite renewed enthusiasm for mRNA treatments.

Don't miss

PayPal’s shares fall after Advent and Stripe abandon a potential acquisition worth more than $50 billion.

The brief

PayPal shares sank after Advent and Stripe abandoned a potential acquisition valued at more than $50 billion, reviving questions about the company’s strategic direction.

Affirm moved higher after issuing a stronger first-quarter revenue forecast and reporting substantial earnings growth, while management said customers remained healthy despite tighter lending.

BioNTech shares fell after it and Roche discontinued an advanced trial of a personalized mRNA cancer vaccine, a setback arriving amid renewed investor interest in mRNA treatments.

The closing preview shifts from market movers to urban growth, examining how AI, long-term planning, and infrastructure blueprints could help cities manage rapid population increases.

What was said on this episode

6 statements · 4 positive · 2 negative

  1. Tatiana Dariaon AffirmPositive2:11

    Affirm has reported substantial earnings growth.

    “But it has also posted huge earnings growth.”

    Listen at 2:11

  2. Tatiana Dariaon BioNTech personalized mRNA cancer vaccineNegative3:33

    BioNTech’s terminated cancer-vaccine trial represents a significant setback.

    “this is a real setback”

    Listen at 3:33

  3. Tatiana Dariaon mRNA cancer treatmentsPositive3:46

    Positive melanoma results raised hopes for mRNA treatments beyond COVID-19.

    “it raised hopes about the mRNA's second act here after COVID.”

    Listen at 3:46

  4. Tatiana Dariaon mRNA technology in solid tumorsNegative3:51

    BioNTech’s setback raises doubts about mRNA technology in solid tumors.

    “this is raising real questions about can this technology work in other tumors, particularly solid tumors”

    Listen at 3:51

  5. Rohit Krishnanon AI in smart citiesPositive5:14

    AI will accelerate processes in smart-city systems.

    “AI will allow in the smart city space to compress a lot of things. the speed will change.”

    Listen at 5:14

  6. Estefanía Tapiason DubaiPositive5:40

    Dubai responded effectively to population growth and has long-term urban planning.

    “they reacted very well to it. They have a long-term urban planning vision”

    Listen at 5:40

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

PayPal deal collapse rattles fintech as Affirm gains | PodLume